Expression patterns of monocarboxylate transporter 2 (MCT2) display mRNA diversity in a tissue-specific fashion. We cloned and characterized multiple mct2 5'-cDNA ends from the mouse and determined the structural organization of the mct2 gene. We found that transcription of this gene was initiated from 5 independent genomic regions that spanned greater than 80 kb on chromosome 10, resulting in 5 unique exon 1 variants (exons 1a, 1b, 1c, 1d, and 1e) that were then spliced to the common exon 2. Alternative splicing of four internal exons (exons AS1, AS2, AS3, and exon 3) greatly increased the complexity of mRNA diversity. While exon 1c was relatively commonly used for transcription initiation in various tissues, other exon 1 variants were used in a tissue-specific fashion, especially exons 1b and 1d that were used exclusively for testis-specific expression. Sequence analysis of 5'-flanking regions upstream of exons 1a, 1b, and 1c revealed the presence of numerous potential binding sites for ubiquitous transcription factors in all three regions and for transcription factors implicated in testis-specific or hypoxia-induced gene expression in the 1b region. Transient transfection assays demonstrated that each of the three regions contained a functional promoter and that the in vitro, cell type-specific activities of these promoters were consistent with the tissue-specific expression pattern of the mct2 gene in vivo. These results indicate that tissue-specific expression of the mct2 gene is controlled by multiple alternative promoters and that both alternative promoter usage and alternative splicing contribute to the remarkable mRNA diversity of the gene.
INTRODUCTION
cap structure. The RNA samples were then treated with tobacco acid pyrophosphatase to remove the cap structure from transcripts with a complete 5' end, leaving an intact 5' monophosphate. An RNA adapter was ligated to those transcripts with the intact 5' monophosphate and the RNA samples were reverse transcribed using decamer random primers and Superscript III reverse transcriptase (Invitrogen). The resulting cDNA pool was used for the 1 st round of PCR amplification using a sense primer compatible with the 5' part of the adapter (5'-GCTGATGGCGATGAATGAACACTG-3') and a gene-specific antisense primer localized in exon 5 of the mouse mct2 gene (GSP1, 5'-CAATGGAGATAAAGGACGCACAGA-3') (29). The PCR product was used as templates for the 2 nd round of PCR using a nested sense primer compatible with the 3' part of the adapter (5'-CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATG-3') and a nested gene-specific antisense primer localized in exon 4 of the mouse mct2 gene (GSP2, 5'-CCAACACACTACTGATGGGACCTC-3') (29). Products from the 2 nd round of PCR were then subcloned into the pCR II vector (TA cloning kit, Invitrogen) and subject to DNA sequence analysis on both strands. The design of the RACE strategy was such that all mRNA diversities upstream of exon 4 where translation of mct2 was initiated would be identified ( Fig. 1A/B ).
Exon 1-specific RT-PCR and Southern blotting
The first strand cDNA was synthesized with total cellular RNA (5 Gg) derived from various mouse organs using random primers and SuperScript III reverse transcriptase. A 532-bp fragment of mouse GAPDH was amplified to verify the quality of all cDNA samples (sense: 5'-AGCCTCGTCCCGTAGACAA-3'; antisense: 5'-CCTTCCACAATGCCAAAGTT-3'). The overall expression pattern of mct2 in these organs was assessed using a primer pair subtending the common region of the mct2 cDNA (sense in exon 4: 5'-ACACCACCTCCAGTCAGAT-3'; antisense in exon 6: 5'-AACCTTTTGTGCTGTTGAT-3') (29). Five exon 1-specific sense primers 
Western blotting analysis
Frozen tissue samples were pulverized and homogenized in sample buffer containing 50 mM Tris-HCl (pH 7.5), 5 mM EDTA, 10 mM EGTA, 10 mM benzamidine, 50 Gg/ml phenylmethylsulfonyl fluoride, 10 Gg/ml aprotinin, 10 Gg/ml leupeptin, 10 Gg/ml pepstatin A, and 10% glycerol (vol/vol) (all chemicals from Sigma-Aldrich). 
Characterization of genomic organization
All newly identified cDNA sequences and the known 5'-cDNA sequence of the mouse antisense: 5'-AGCACCGCCTTTACCTGACTCT-3'). The 1a and 1b fragments were directly inserted, whereas the 1c fragment was digested with FspI and the 3240-bp fragment was then inserted, into the BglII site, which had been made blunt-ended, in the poly-linker of the promoterless luciferase reporter vector pGL2/Basic (Promega) such that the expression of the firefly luciferase reporter was under the control of the inserted mouse genomic DNA fragments.
Transient expression of these promoter-reporter constructs was assessed in LA-4 (mouse lung epithelium, ATCC) and Neuro-2a (mouse neuroblastoma, ATCC) cells. Cells were grown in 6-well plates to 40-50% confluence and were transfected with 2 Gg of the DNA constructs and 4 Gl of GenePORTER 2 reagent (Gene Therapy Systems) per well. The pGL2/Control vector (Promega) whose reporter was under the control of the robust heterologous SV40 promoter was used as a positive control and the promoter-less pGL2/Basic vector as a negative control. A renilla luciferase expression vector (phRL-TK, Promega) was co-transfected to control for transfection efficiency across wells. Forty-eight hours after transfection, cells were lysed and assayed for luciferase activity using the Dual-Luciferase® Reporter Assay System (Promega) and a microplate reader (Victor 3 V, PerkinElmer). A total of six batches of transfection were performed, with each being conducted in duplicated wells.
RESULTS

Cloning of multiple exon 1 variants and their genomic organization
A total of 68 5'-RACE clones derived from the 4 organs, including the brain, the skeletal muscle, the lung, and the testis, were analyzed. The 5' ends of these clones were believed to represent true transcription start sites since the improved 5'-RACE protocol targeted only capped mRNA transcripts. A comparison with the overall structural organization of the mouse mct2 gene demonstrated that all clones contained a common 3' sequence that was identical to the 5' end of exon 4, but divergent 5' sequences that occurred upstream of the first nucleotide of exon 2 ( Fig 1A) . Mapping of these 5'-cDNA sequences with the Mouse Genome Database indicated that these divergent sequences were led by four unique exons designated as exons 1a, 1b, 1c, and 1d, respectively, based on the order in which they were identified (Fig. 1 ). Of note, the 1a sequence was similar to the 5' end of the published mct2 cDNA sequence (29), but had a longer 5' end. While exons 1a, 1b, and 1d were spliced directly to the common exon 2, exon 1c was spliced to exon 2 via complex combinations of three alternatively spliced internal exons, termed AS1, AS2, and AS3 based on their 5' to 3' order in the mouse genome (Fig. 1,   2A /B). A search of mouse ESTs identified an additional exonic sequence derived from the mct2 gene (Accession number AI315949). This unique sequence was originally cloned from the kidney and comprised of, in the 5' to 3' order, a 5'-leader exon, AS2, AS3, exon 2, and exon 4
( Fig. 1, 2A /B). The 5'-leader exon of this EST was deemed to be an exon 1 (1e) rather than an internal exon although it was localized between AS1 and AS2 ( Fig. 2A/B ) because it was not alternatively spliced in any transcripts initiated from exon 1c and it was not preceded by a splicing acceptor sequence. These novel 5'-exonic sequences, including five leading exons and three internal exons, were distributed over a genomic region greater than 80 kb in mouse chromosome 10 ( Fig. 2A) . All exon-intron boundaries conformed to the GT/AG rule (36).
Interestingly, as the EST (AI315949), the vast majority of the 5'-RACE clones lacked exon 3.
Alternative splicing of this internal exon further increased the complexity of splicing patterns utilized by this gene (Fig. 2C ). Since stop codons were evident in all three translation reading frames upstream of the initiating AUG in exon 4, all newly identified sequences represented mct2 mRNA diversity within the 5'-untranslated region (5'-UTR) and did not affect the structure of the encoded protein.
Tissue-specific expression of alternative exon 1 variants
An exon 1-specific RT-PCR approach was used to determine the expression patterns of each mouse mct2 exon 1 in normal tissues. Consistent with the trend noticed in 5'-RACE, the alternative exon 1 variants were expressed in a tissue-specific fashion when compared with PCR amplifications subtending the common region (exon 4-6, within the open reading frame) (Fig. 3) . Notably, exons 1b and 1d were expressed almost exclusively in the testis, although very low levels of 1b were detected in a few other tissues. In contrast, exons 1a, 1c, and 1e
were expressed in multiple tissues. In particular, exon 1c was ubiquitously expressed in all tissues with relatively uniform intensity, whereas exons 1a and 1e were also expressed in multiple tissues but the expression intensity varied greatly among different tissues. For example, 1a was highly expressed in the lung, the liver, the kidney, and the bladder, but was only marginally expressed in brain tissues, and 1e was mainly expressed in the kidney and the heart.
In line with the finding made in 5'-RACE, exon 3 was found to be excluded from most mct2 transcripts under normal conditions, especially those initiated from exons 1a, 1b, and 1d ( Fig.   3A ). The identities of the high and low molecular-weight PCR amplicons were examined by cloning and sequencing and were confirmed to be those with or without exon 3, respectively.
Additional confirmation was obtained by using an oligonucleotide probe located in exon 3 to reprobe the Southern blots (Fig. 3B ). Meanwhile, mct2 mRNA transcripts initiated from exons 1c and 1e were accentuated by intricate alternative splicing of AS1, AS2, AS3, and exon 3 with a tissue-specific flavor (Fig. 3 ). For example, more than 10 different PCR products could be recognized from transcripts initiated from 1c, although only 5 such variants were physically cloned in 5'-RACE as shown in Fig. 2B . A similar pattern was observed with 1e-initiated transcripts. Given the extraordinary complexity of these 1c-and 1e-initiated transcripts, no additional attempt was made to clarify the molecular nature of these PCR products.
Interestingly, sizes and relative densities of these PCR products differed among different tissues, suggesting the existence of tissue-specific and regulated alternative splicing mechanisms.
The relative expression levels of exon 1a-, 1b-, 1d-, and 1e-specific transcripts in several important organs, including the brain, the lung, the liver, the kidney, the heart, and the testis, revealed that the expression level of 1a in the kidney was substantially higher than, rather than being similar to, those in the lung and the liver (Fig. 4A ). It also detected marginal expression of 1d in both the brain and the lung (Fig. 4C) , which was not seen using RT-PCR plus Southern blotting (Fig. 3A) . Conversely, marginal expression of 1b in the brain and the kidney and 1e in the brain and the lung as seen using RT-PCR plus Southern blotting ( variants in various tissues assessed using both methods are summarized in Table 1 .
Interestingly, mct2 mRNA expression ( Sequence inspection of the proximal regions (-1200 bp) of the three promoters revealed that only 1b contained a TATA-like element (CATAAAWG) in the core promoter region near the transcription start site (-23) (Fig. 7) . However, numerous potential binding sites for ubiquitous transcription factors were evident in all three promoters (Fig. 7) . For example, the 1a promoter comprised two CAAT boxes (-180 and -789), a strong Sp1 site (-382), an NF-Y site (-618), and two AP1 sites (-892 and -1003). In the 1b promoter, a CAAT box (-157) and an Sp1 site (-373) were closely localized with the TATA-like element. Interestingly, this region contained 3 copies of the steroidogenic factor 1 (SF-1) biding site (252, -364, and -1132) that was thought to be important to testis-specific gene expression (4, 32) . And finally, the 1c promoter possessed two strong Sp1 sites (33 and 151), two insulin response elements (IRE, 35 and 244), one of which overlapped with the proximal Sp1 site, an upstream CAAT box (-832), a GATA site (-271), and three AP-1 sites (188, -332, and -564).
DISCUSSION
The current study shows that the mouse mct2 gene is a highly complex locus whose expression in diverse tissues is likely initiated by multiple alternative promoters. This notion is supported by the following lines of evidence: (1) lactate metabolism under hypoxic conditions. However, it was noted that the human MCT1
promoter and the two human MCT2 promoters tested in the same study were not responsive to hypoxia (56) .
The fact that all five mct2 promoters are active in the testis appears to contradict the concept of "alternative promoters". It is possible that in this case multiple promoters serve as a safeguard mechanism that secures proper expression of a vital gene. Recent studies have implicated MCT2 in spermatogenesis and other important testicular functions (9, 10, 20, 25). A sustained lactate transporter activity might be vital to these functions, such that additional security measures may have developed through evolution to preserve the expression of this transporter. Indeed, two of the five mct2 promoters are shown to be designated specifically for this organ. It would be a fascinating topic as to how these promoters are coordinated to achieve the level of expression of mct2 proper to the vital organ of the testis. Alternatively, the five promoters might direct mct2 expression in different types of cells within the testis. The biological significance of these promoters within this important organ will require additional investigation.
In addition to alternative promoter usage, alternative splicing of pre-mRNA transcripts, especially those derived from exons 1c and 1e, is a major contributor to mct2 mRNA diversity (Fig. 3) . The alternative splicing patterns of these transcripts are so complex that it is difficult, if not impossible, to determine the molecular identity for each one of them. However, alternative inclusion of exon 1a, 1b, 1d, or 1e in 1c transcripts has been ruled out since Southern blotting analysis of the 1c-specific PCR products using probes located in these exons did not detect any bands (data not shown). It is conceivable that the various 1c transcripts are products of alternative splicing of internal exons AS1, AS2, AS3, and possibly exon 3 and that the 1e transcripts are derived from alternative splicing of exons AS2, AS3, and possibly exon 3. Of note, while exon 3 was predominantly excluded among mct2 transcripts from C57BL/6 mice as shown in the current study, it was included in a cDNA cloned from 129 mice (Accession number AF058054) (29). It is unclear whether the latter reflects a true strain-based preference in the usage of this exon or just a random occurrence in a single cDNA sequence. Furthermore, recent studies demonstrated that the mct2 indeed was regulated at the translational level (14, 25, 43). It is thus reasonable to assume at this time that the remarkable mRNA diversity of the mouse mct2 gene is more than a mere consequence of the need to initiate transcription from different genomic locations, and in fact may represent an additional regulatory mechanism that insures appropriate expression of this important gene under various conditions in diverse tissues.
In summary, we demonstrate that transcription of the mct2 gene is initiated from five distinct variants of exon 1, likely under the control of five alternative promoters, and that a large number of mature mRNA are produced from these pre-mRNA through alternative splicing of multiple internal exons in the 5'-UTR. Both alternative promoter usage and alternative splicing may contribute to the tissue-specific expression pattern of mct2 and may also be involved in development-specific and environmental stress-induced expression of this important gene. 
